Commercial Weight Management Program May Help Prevent T2D

Share this content:
Commercial Weight Management Program May Help Prevent T2D
Commercial Weight Management Program May Help Prevent T2D

TUESDAY, Oct. 17, 2017 (HealthDay News) -- Primary care referral along with a commercial weight management provider can deliver an effective diabetes prevention program (DPP), according to a study published online Oct. 16 in BMJ Open Diabetes Research & Care.

Carolyn Piper, from the Department of Public Health in London, and colleagues evaluated whether a DPP delivered by a commercial weight management company using a primary care referral pathway could reduce progression to type 2 diabetes. A total of 166 patients with non-diabetic hyperglycemia were referred by 14 primary care practices. The intervention included an initial 90-minute session followed by 48 weekly Weight Watchers group meetings.

Of the referred patients, 149 were eligible to participate; 79 percent of them attended an activation session, and 77 percent started the weekly sessions (75 percent female, 90 percent white). The researchers found that DPP resulted in a mean reduction in HbA1c of 2.84 mmol/mol at 12 months. More than one-third of patients (38 percent) returned to normoglycemia, while 3 percent developed type 2 diabetes at 12 months. Over the 12-month period there was a mean weight reduction in BMI of 3.2 kg/m2.

"The lifestyle changes and weight loss achieved in the intervention translated into considerable reductions in diabetes risk, with an immediate and significant public health impact," conclude the authors.

One author reports financial ties to Weight Watchers, which helped fund the study.

Abstract/Full Text

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Dozens of Medical Groups Join Forces to Improve Diagnoses

Dozens of Medical Groups Join Forces to Improve ...

Diagnostic error is the most common cause of medical errors that patients report

HbA1c Variability Is a Strong Predictor of Mortality in T2DM

HbA1c Variability Is a Strong Predictor of Mortality ...

HbA1c variability is a powerful, independent measure, regardless of how it is measured

Pediatric End-Stage Liver Disease Score Underestimates Mortality

Pediatric End-Stage Liver Disease Score Underestimates Mortality

Actual probability of death for patients on liver transplant wait list underestimated by up to 17%

is free, fast, and customized just for you!




Already a member?

Sign In Now »